1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
APEX Tech Acquisition Inc. (TRAD) said its board appointed Florence Ng, age 62, as Chief Executive Officer effective July 20, 2026, replacing Shaoren Liu, who resigned as CEO the same day. Liu remains Chief Financial Officer, Chairman and a director, and the filing says his resignation was not due to any disagreement with the company.
Florence Ng, 62, appointed CEO effective July 20, 2026, with over 17 years of experience in mergers and acquisitions, capital markets and corporate governance.
Shaoren Liu resigned as CEO effective July 20, 2026, and continues as CFO, Chairman and director.
The company entered into a Service Agreement with Ng, filed as Exhibit 10.1.
Danaher reported second-quarter 2026 revenue of $6.3 billion, up 5.5% year-over-year, and GAAP net earnings of $870 million, or $1.23 per diluted share, up 60%. The company raised its full-year 2026 adjusted diluted EPS guidance to $8.45-$8.60 from $8.35-$8.55, which points to higher expected per-share profit for shareholders.
Q2 2026 adjusted diluted EPS was $1.94, up 8.0% year-over-year, and non-GAAP core revenue rose 3.0%.
Full-year 2026 adjusted diluted EPS guidance rose to $8.45-$8.60 from $8.35-$8.55.
Third-quarter 2026 core revenue growth is expected at 2.0% to 3.0%, and full-year core revenue growth at 3.0% to 4.0%.
Operating cash flow was $1.5 billion and free cash flow was $1.3 billion in the quarter, and the Masimo acquisition closed earlier than anticipated.
Drugs Made In America Acquisition Corp. filed Amendment No. 3 to its merger agreement with Power Analytics Global Corp, dated July 14, 2026. The amendment requires the former sponsor to forfeit at least 50% of its founder shares, sets a $0.25 to $0.35 per-right tender offer for public rights, and restates minimum cash at a $30 million target and $15 million floor. Shareholders are affected by these changes to dilution, cash at closing, and the affiliated-party structure, which the filing says includes a fairness opinion condition.
Sponsor must forfeit at least 50% of founder shares and surrender 430,000 private placement rights for no consideration.
The company agreed to launch a cash tender, exchange offer, or consent solicitation for public rights at $0.25 to $0.35 per right, before or with the proxy mailing.
Minimum cash target is $30,000,000 with a $15,000,000 floor.
A contingent Amendment No. 4 for a possible three-party combination takes effect only if conditions are met by September 30, 2026.
Lionheart Holdings, a special purpose acquisition company, said it signed a non-binding letter of intent dated July 15, 2026, with Keo Capital AB on behalf of KEO Energy for a potential business combination. The preliminary indicative pre-money enterprise value for KEO Energy is $400 million, and the parties target a definitive agreement by August 17, 2026, but no assurances are given that a deal will be reached.
Letter of intent dated July 15, 2026, announced July 20, 2026
Preliminary indicative pre-money enterprise value for KEO Energy of $400 million, subject to diligence and Venezuelan approvals
Definitive agreement targeted for August 17, 2026; closing requires OFAC authorization and Venezuelan governmental approvals
Lionheart holds approximately $200 million in its trust account
AdaptHealth agreed on July 19, 2026 to sell substantially all assets of its Diabetes Health business to RGH Enterprises, a subsidiary of Cardinal Health, for $235.0 million in cash, subject to a working capital adjustment. The company says the sale lets it redeploy capital to core sleep and respiratory businesses and reduce debt, but it has not yet disclosed the financial effect, which it will cover on its August 4, 2026 earnings call.
Purchase price is $235.0 million in cash, with $8.0 million and $18.8 million placed in escrow at closing for price adjustment and indemnification obligations
Closing requires Hart-Scott-Rodino antitrust clearance and other customary conditions; either party may terminate if closing has not occurred within twelve months, and a $9.4 million termination fee applies in certain antitrust failure case
AdaptHealth agreed to a four-year non-compete in North America following closing
Company will discuss financial and guidance effects, including discontinued operations treatment, on its Q2 2026 earnings call on August 4, 2026
Crown Holdings reported second quarter 2026 results on July 20, 2026, with adjusted diluted earnings per share up 16% to $2.49 from $2.15 a year earlier. The company raised its full-year 2026 adjusted diluted EPS guidance to $8.30 to $8.50 from $7.90 to $8.30, which signals higher expected profit for shareholders.
Q2 2026 net sales were $3,668 million versus $3,149 million in Q2 2025; reported diluted EPS was $2.23 versus $1.56.
Full-year 2026 adjusted diluted EPS guidance raised to $8.30 to $8.50; third-quarter adjusted diluted EPS expected at $2.20 to $2.30.
Share repurchases were $305 million in Q2 2026 and more than $500 million in the first six months; net leverage ratio was 2.5x.
Adjusted free cash flow for 2026 is expected to be at least $900 million after capital spending of approximately $550 million.
FinWise Bancorp said it completed an acquisition of the technology platform and related assets of Tallied Technologies, the card issuing and processing platform that already powered the bank's co-branded credit card programs. The company expects about $4.0 million in integration and transition costs over the next year, and says its prior guidance of approximately $217 million in credit-enhanced balances by the end of 2026 no longer applies, which shareholders will need to weigh against the expected revenue retention.
Acquired Tallied platform and related assets, with live programs already running on it
Integration and transition costs of approximately $4.0 million over the next year, expected to be higher in the next two quarters
About $50 million of credit card balances will move onto the Bank's balance sheet, and prior guidance of approximately $217 million in credit-enhanced balances by end of 2026 no longer applies
Second quarter 2026 results and conference call scheduled for July 29, 2026 at 5:00 p.m. ET
Cracker Barrel completed a sale-leaseback of 26 stores for approximately $77 million in net proceeds, which it plans to use to reduce debt. It also sold assets of its Maple Street Biscuit Company business to Biscuit Belly, LLC and will close the remaining 16 MSBC locations, with expected non-cash charges of $37 million to $39 million and cash charges of $6 million to $8 million. The company now expects to achieve or exceed the high end of its fiscal 2026 revenue range and exceed its adjusted EBITDA outlook, though the charges will weigh on reported results in the fourth quarter.
Sale-leaseback: 26 Cracker Barrel stores sold to an institutional real estate investor, effective July 17, 2026, with initial annual lease payments of about $5.7 million
MSBC: 35 locations and trademarks sold to Biscuit Belly, LLC on July 20, 2026; remaining 16 locations to close; MSBC contributed less than 2% of annual revenue
Charges: non-cash charges of $37 million to $39 million and cash charges of $6 million to $8 million, with estimates described as preliminary
Outlook: fiscal 2026 revenue range previously $3.27 billion to $3.30 billion and adjusted EBITDA of $120 million to $125 million; comparable store restaurant sales fell about 2.5% in the first eleven weeks of the fourth quarter
H.B. Fuller signed Amendment No. 3 to its credit agreement with JPMorgan Chase Bank on July 17, 2026, refinancing its term A loans and revolving loans and extending their maturity to July 17, 2031. The company also terminated a $2,086,713,188 secured bridge credit agreement from June 2026 with no amounts outstanding, and the revolving facility's size rose to $800 million. The filing states the interest margins on the refinanced loans fell by 25 basis points, which lowers borrowing costs on those facilities.
Term A loans refinanced at $420,000,000; revolving loans refinanced at $700,000,000
Revolving credit facility increased by $100,000,000 to $800,000,000 total
Maturity extended to July 17, 2031; interest margins cut by 25 basis points (0.25% per annum)
Secured Bridge Credit Agreement dated June 25, 2026 terminated with no loans outstanding and no prepayment premium
Lightwave Logic, Inc. appointed Fred A. Graffam III as Chief Financial Officer effective July 20, 2026. Per the press release, he will oversee financial operations, reporting, capital allocation and investor relations. Snizhana "Ana" Quan, previously Principal Financial Officer and Principal Accounting Officer, will remain with the company as Vice President of Finance and Corporate Controller.
Graffam, age 60, was CFO of Fidium (formerly Consolidated Communications) from December 2022 to April 2026, and is a certified public accountant
Annual base salary of $450,000, with a discretionary annual performance bonus of up to 40% of base salary
Sign-on cash bonus of $70,000 and sign-on restricted stock units with an aggregate grant-date value of $2,400,000
Severance includes two times base salary and two times target bonus if terminated within twelve months after a change in control
Kalaris Therapeutics appointed Liisa Bayko as Chief Financial Officer and Treasurer, effective July 20, 2026, and she will also serve as principal financial officer. The company also disclosed that Chief Accounting Officer Brett Hagen is resigning effective July 27, 2026, and Corporate Controller Amy Vandekop will serve as interim principal accounting officer.
Liisa Bayko's annualized base salary is $475,000, with an annual target bonus of up to 40.0% of base salary.
Bayko received an incentive stock option to purchase up to 220,000 shares of common stock, vesting 25% on the first anniversary of the effective date and then in 36 monthly installments.
Bayko previously was Managing Director, Biotech Equity Research at Evercore ISI from August 2020 to December 2025.
Brett Hagen notified the company on July 14, 2026 of his resignation as SVP, Finance and Chief Accounting Officer, effective July 27, 2026.
Magnolia Oil & Gas agreed on July 19, 2026 to acquire WildFire Energy's intermediate holding company, with total consideration the company values at approximately $4.06 billion including WildFire's debt. The deal requires $2.65 billion in cash and 32.2 million Magnolia shares, and closing is expected late in the third quarter of 2026, subject to conditions including HSR antitrust clearance. The company also raised its quarterly dividend 9% to $0.18 per share and plans a new $2.25 billion revolving credit facility to fund the deal.
Cash consideration of $2,650 million plus 32,203,000 Magnolia Class A common shares, and assumption of $600 million of 7.500% Senior Notes due 2029
Amended and restated reserve-based revolving credit facility with $2.25 billion maximum commitments and $1.75 billion borrowing capacity, effective upon closing
$1.50 billion senior unsecured 364-day bridge facility committed by lenders; $200 million escrow deposit made on signing
Quarterly dividend raised to $0.18 per share from $0.165, payable in the third quarter of 2026; closing expected late in Q3 2026
LXP Industrial Trust signed a merger agreement on July 19, 2026 to be acquired by Leopard REIT LLC, a vehicle of Brookfield and CPP Investments, for $61.20 per common share in cash. Exhibit 99.1 says the transaction is valued at about $5.2 billion including net debt and preferred equity, and the price is a 12.3% premium to the 30-day VWAP and 19.8% to the 90-day VWAP as of July 17, 2026. Completion requires shareholder approval and is expected in the fourth quarter of 2026.
Merger consideration: $61.20 per common share in cash, without interest
Go-shop period runs until 11:59 p.m. New York City time on August 28, 2026
Termination fee of $54,122,768 if the company terminates for a superior proposal before the September 2, 2026 cut-off; $108,245,537 in certain other cases
Company must suspend regular quarterly dividends during the merger, except those needed to maintain REIT status
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.